Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Enrolling by invitation Not applicable

Use of TrachPhone in Tracheostomized Patients

NCT06487104 · tracked via the Priya Life Science UK tracker
Sponsor
Atos Medical AB
Phase
Not applicable
Started
2025-02-05
Last updated
2026-07-14

Condition(s) studied

Tracheostomy

Investigational drug(s) / intervention(s)

TrachPhone HMEExternal Humidifier (Usual Care)

TrachPhone HME: Use of TrachPhone HME for humidification of inhaled air in tracheostomized patients. The TrachPhone HME is an HME specifically designed for tracheostomy patients.

External Humidifier (Usual Care): Usual care routines using an External Humidifier for humidification of inhaled air in tracheostomized patients.

Study summary

The use of Heat and Moisture Exchangers (HMEs) and their positive impact on pulmonary health have been extensively studied in patients with head and neck cancer but have not been systematically explored in other patient populations breathing through a neck stoma.

The objective of this clinical investigation is to compare the use of HMEs to the use of External Humidifiers (EHs) on pulmonary secretion management, their usability and safety, for humidifying inhaled air in patients that received a tracheostomy due to a neurological condition.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Tracheostomy patient outside critical care * Self-ventilating via a tracheostomy tube, independent of cuff status * 18 years or older Exclusion Criteria: * Patients with tidal volume beyond recommended range (50-1000 ml) * Dehydration * Very heavy/excessive secretion from the lungs and airways (requiring more frequently tracheal suction, more than hourly suctioning) * High oxygen need (FiO2 \> 0.4) * Acutely deteriorating patient

Primary outcome measure(s)

  • Number of suctioning per day — At Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)
    Times per day suctioning is required

Trial sites (1)

FacilityCityRegionStatus
The Royal London Hospital, Barts Health NHS Trust London United Kingdom
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06487104 on ClinicalTrials.gov ↗ ← All trials in the UK